S217879 disrupts the interaction between KEAP1 and Nrf2, thus triggering an enhancement of antioxidant pathways and the associated regulation of multiple genes involved in NASH disease progression. Here, KEAP1 is linked to metabolic dysfunction-associated steatohepatitis.